Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-26
DOI
10.3389/fphys.2018.00452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Galectins in Tumors and in Clinical Immunotherapy
- (2018) Feng-Cheng Chou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study
- (2017) Tomoko Tadokoro et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Regulatory T Cell–Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9
- (2017) Shravan Madireddi et al. JOURNAL OF IMMUNOLOGY
- Prognostic value of tumoral expression of galectin-9 in gastric cancer
- (2017) Sang Il Choi et al. Turkish Journal of Gastroenterology
- Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
- (2017) Yidong Liu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- MicroRNA profiles during galectin‑9‑induced apoptosis of pancreatic cancer cells
- (2017) Ryoichi Okura et al. Oncology Letters
- Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature
- (2017) Sara M. Melief et al. Cancer Immunology Research
- PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
- (2017) Kostandinos Sideras et al. OncoImmunology
- The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
- (2017) Isabel Gonçalves Silva et al. EBioMedicine
- Galectin-9: An anticancer molecule for gallbladder carcinoma
- (2016) TOMOKO TADOKORO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Modes of invasion during tumour dissemination
- (2016) Pahini Pandya et al. Molecular Oncology
- Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway
- (2016) Yang Wang et al. PLoS One
- Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
- (2016) Andrée-Anne Grosset et al. Oncotarget
- Abstract A008: Discriminant function for predicting survival of lung adenocarcinoma patients developed by using immune parameters of PD-L1, Gal-9, and XAGE1 expression on tumor cells and T cell infiltration score
- (2016) Yoshihiro Ohue et al. Cancer Immunology Research
- Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
- (2015) KOJI FUJITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest
- (2015) KIYOYUKI KOBAYASHI et al. ONCOLOGY REPORTS
- Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
- (2015) Hangcheng Fu et al. TUMOR BIOLOGY
- Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
- (2014) K. Nagahara et al. JOURNAL OF IMMUNOLOGY
- Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
- (2014) Iris A. Schulkens et al. PLoS One
- Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
- (2013) Jing Jiang et al. PLoS One
- Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
- (2012) Zhao-Yang Zhang et al. Asian Pacific Journal of Cancer Prevention
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
- (2012) Valerie R. Wiersma et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Classifying collective cancer cell invasion
- (2012) Peter Friedl et al. NATURE CELL BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages
- (2011) Takeshi Kadowaki et al. CLINICAL IMMUNOLOGY
- Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
- (2010) T Kobayashi et al. LEUKEMIA
- Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
- (2010) J. Kuroda et al. MOLECULAR CANCER RESEARCH
- Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice
- (2008) Atsuya Nobumoto et al. CLINICAL IMMUNOLOGY
- Different roles of galectin-9 isoforms in modulating E-selectin expression and adhesion function in LoVo colon carcinoma cells
- (2008) Feng Zhang et al. MOLECULAR BIOLOGY REPORTS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started